These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 11687170)

  • 1. Treatment for amphetamine withdrawal.
    Srisurapanont M; Jarusuraisin N; Kittirattanapaiboon P
    Cochrane Database Syst Rev; 2001; (4):CD003021. PubMed ID: 11687170
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment for amphetamine withdrawal.
    Shoptaw SJ; Kao U; Heinzerling K; Ling W
    Cochrane Database Syst Rev; 2009 Apr; 2009(2):CD003021. PubMed ID: 19370579
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment for amphetamine dependence and abuse.
    Srisurapanont M; Jarusuraisin N; Kittirattanapaiboon P
    Cochrane Database Syst Rev; 2001; (4):CD003022. PubMed ID: 11687171
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment for amphetamine psychosis.
    Srisurapanont M; Kittiratanapaiboon P; Jarusuraisin N
    Cochrane Database Syst Rev; 2001; (4):CD003026. PubMed ID: 11687172
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment for amphetamine psychosis.
    Shoptaw SJ; Kao U; Ling WW
    Cochrane Database Syst Rev; 2008 Oct; (4):CD003026. PubMed ID: 18843639
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment for amphetamine psychosis.
    Shoptaw SJ; Kao U; Ling W
    Cochrane Database Syst Rev; 2009 Jan; 2009(1):CD003026. PubMed ID: 19160215
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amphetamine withdrawal: II. A placebo-controlled, randomised, double-blind study of amineptine treatment.
    Srisurapanont M; Jarusuraisin N; Jittiwutikan J
    Aust N Z J Psychiatry; 1999 Feb; 33(1):94-8. PubMed ID: 10197891
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antipsychotics for cocaine or psychostimulant dependence: systematic review and meta-analysis of randomized, placebo-controlled trials.
    Kishi T; Matsuda Y; Iwata N; Correll CU
    J Clin Psychiatry; 2013 Dec; 74(12):e1169-80. PubMed ID: 24434105
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Withdrawal versus continuation of chronic antipsychotic drugs for behavioural and psychological symptoms in older people with dementia.
    Declercq T; Petrovic M; Azermai M; Vander Stichele R; De Sutter AI; van Driel ML; Christiaens T
    Cochrane Database Syst Rev; 2013 Mar; (3):CD007726. PubMed ID: 23543555
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cognitive behaviour therapy for schizophrenia.
    Cormac I; Jones C; Campbell C
    Cochrane Database Syst Rev; 2002; (1):CD000524. PubMed ID: 11869579
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thioridazine for schizophrenia.
    Sultana A; Reilly J; Fenton M
    Cochrane Database Syst Rev; 2000; (3):CD001944. PubMed ID: 10908517
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Perazine for schizophrenia.
    Leucht S; Hartung B
    Cochrane Database Syst Rev; 2002; (1):CD002832. PubMed ID: 11869638
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological treatment for methamphetamine withdrawal: A systematic review and meta-analysis of randomised controlled trials.
    Acheson LS; Williams BH; Farrell M; McKetin R; Ezard N; Siefried KJ
    Drug Alcohol Rev; 2023 Jan; 42(1):7-19. PubMed ID: 35862266
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Haloperidol versus placebo for schizophrenia.
    Joy CB; Adams CE; Lawrie SM
    Cochrane Database Syst Rev; 2001; (2):CD003082. PubMed ID: 11406070
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of cellulose, modified cellulose and synthetic membranes in the haemodialysis of patients with end-stage renal disease.
    MacLeod A; Daly C; Khan I; Vale L; Campbell M; Wallace S; Cody J; Donaldson C; Grant A
    Cochrane Database Syst Rev; 2001; (3):CD003234. PubMed ID: 11687058
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risperidone versus other atypical antipsychotic medication for schizophrenia.
    Gilbody SM; Bagnall AM; Duggan L; Tuunainen A
    Cochrane Database Syst Rev; 2000; (3):CD002306. PubMed ID: 10908551
    [TBL] [Abstract][Full Text] [Related]  

  • 17. WITHDRAWN: Cognitive behaviour therapy versus other psychosocial treatments for schizophrenia.
    Jones C; Hacker D; Meaden A; Cormac I; Irving CB
    Cochrane Database Syst Rev; 2011 Apr; (4):CD000524. PubMed ID: 21491377
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pre-operative endometrial thinning agents before endometrial destruction for heavy menstrual bleeding.
    Tan YH; Lethaby A
    Cochrane Database Syst Rev; 2013 Nov; (11):CD010241. PubMed ID: 24234875
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of psychostimulant drugs for amphetamine abuse or dependence.
    Pérez-Mañá C; Castells X; Torrens M; Capellà D; Farre M
    Cochrane Database Syst Rev; 2013 Sep; (9):CD009695. PubMed ID: 23996457
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gamma-hydroxybutyrate (GHB) for treatment of alcohol withdrawal and prevention of relapses.
    Leone MA; Vigna-Taglianti F; Avanzi G; Brambilla R; Faggiano F
    Cochrane Database Syst Rev; 2010 Feb; (2):CD006266. PubMed ID: 20166080
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.